GAPO syndrome: Difference between revisions
CSV import |
CSV import |
||
| Line 1: | Line 1: | ||
[[File:GLH_alopecia.png|GLH alopecia|thumb]] '''GAPO syndrome''' is a rare [[genetic disorder]] characterized by a combination of [[growth retardation]], [[alopecia]], [[pseudoanodontia]], and [[optic atrophy]]. The name GAPO is an acronym derived from these primary features. The syndrome is inherited in an [[autosomal recessive]] manner. | {{SI}} | ||
{{Infobox medical condition | |||
| name = GAPO syndrome | |||
| image = [[File:Autosomal_recessive_-_en.svg|200px]] | |||
| caption = GAPO syndrome is inherited in an [[autosomal recessive]] pattern. | |||
| synonyms = Growth retardation, Alopecia, Pseudoanodontia, and [[Optic atrophy]] | |||
| field = [[Medical genetics]] | |||
| symptoms = [[Growth retardation]], [[alopecia]], [[pseudoanodontia]], [[optic atrophy]] | |||
| onset = [[Infancy]] | |||
| duration = Lifelong | |||
| causes = Mutations in the [[ANAPC1]] gene | |||
| risks = Family history of the condition | |||
| diagnosis = [[Genetic testing]], clinical evaluation | |||
| differential = Other syndromes with similar features | |||
| treatment = Symptomatic management | |||
| prognosis = Variable, depending on severity | |||
| frequency = Rare | |||
}} | |||
[[File:GLH_alopecia.png|GLH alopecia|left|thumb]] '''GAPO syndrome''' is a rare [[genetic disorder]] characterized by a combination of [[growth retardation]], [[alopecia]], [[pseudoanodontia]], and [[optic atrophy]]. The name GAPO is an acronym derived from these primary features. The syndrome is inherited in an [[autosomal recessive]] manner. | |||
== Signs and Symptoms == | == Signs and Symptoms == | ||
Individuals with GAPO syndrome typically present with the following features: | Individuals with GAPO syndrome typically present with the following features: | ||
* | * '''Growth retardation''': Affected individuals exhibit significantly reduced growth rates, leading to short stature. | ||
* | * '''Alopecia''': There is a notable absence of hair, including scalp hair, eyebrows, and eyelashes. | ||
* | * '''Pseudoanodontia''': This refers to the delayed eruption or absence of teeth. | ||
* | * '''Optic atrophy''': Progressive degeneration of the [[optic nerve]] leading to vision impairment. | ||
Additional features may include [[hearing loss]], [[skin abnormalities]], and [[cardiovascular anomalies]]. | Additional features may include [[hearing loss]], [[skin abnormalities]], and [[cardiovascular anomalies]]. | ||
== Genetics == | == Genetics == | ||
GAPO syndrome is caused by mutations in the [[ANKRD11]] gene, which plays a role in [[chromatin remodeling]] and [[gene expression]]. The disorder follows an autosomal recessive inheritance pattern, meaning that an individual must inherit two copies of the mutated gene, one from each parent, to be affected. | GAPO syndrome is caused by mutations in the [[ANKRD11]] gene, which plays a role in [[chromatin remodeling]] and [[gene expression]]. The disorder follows an autosomal recessive inheritance pattern, meaning that an individual must inherit two copies of the mutated gene, one from each parent, to be affected. | ||
== Diagnosis == | == Diagnosis == | ||
Diagnosis of GAPO syndrome is primarily based on clinical evaluation and the presence of characteristic features. Genetic testing can confirm the diagnosis by identifying mutations in the ANKRD11 gene. | Diagnosis of GAPO syndrome is primarily based on clinical evaluation and the presence of characteristic features. Genetic testing can confirm the diagnosis by identifying mutations in the ANKRD11 gene. | ||
== Management == | == Management == | ||
There is no cure for GAPO syndrome, and treatment is symptomatic and supportive. Management may involve: | There is no cure for GAPO syndrome, and treatment is symptomatic and supportive. Management may involve: | ||
| Line 22: | Line 35: | ||
* Dental care to address pseudoanodontia | * Dental care to address pseudoanodontia | ||
* Supportive therapies for any additional complications | * Supportive therapies for any additional complications | ||
== Epidemiology == | == Epidemiology == | ||
GAPO syndrome is extremely rare, with fewer than 50 cases reported in the medical literature. It affects both males and females equally. | GAPO syndrome is extremely rare, with fewer than 50 cases reported in the medical literature. It affects both males and females equally. | ||
== See Also == | == See Also == | ||
* [[Genetic disorder]] | * [[Genetic disorder]] | ||
| Line 32: | Line 43: | ||
* [[Growth retardation]] | * [[Growth retardation]] | ||
* [[Pseudoanodontia]] | * [[Pseudoanodontia]] | ||
== References == | == References == | ||
{{Reflist}} | {{Reflist}} | ||
== External Links == | == External Links == | ||
{{No external links}} | {{No external links}} | ||
[[Category:Genetic disorders]] | [[Category:Genetic disorders]] | ||
[[Category:Rare diseases]] | [[Category:Rare diseases]] | ||
[[Category:Autosomal recessive disorders]] | [[Category:Autosomal recessive disorders]] | ||
[[Category:Medical genetics]] | [[Category:Medical genetics]] | ||
{{medicine-stub}} | {{medicine-stub}} | ||
Latest revision as of 02:20, 7 April 2025

Editor-In-Chief: Prab R Tumpati, MD
Obesity, Sleep & Internal medicine
Founder, WikiMD Wellnesspedia &
W8MD's medical weight loss NYC, sleep center NYC
Philadelphia medical weight loss and Philadelphia sleep clinics
| GAPO syndrome | |
|---|---|
| Synonyms | Growth retardation, Alopecia, Pseudoanodontia, and Optic atrophy |
| Pronounce | N/A |
| Specialty | N/A |
| Symptoms | Growth retardation, alopecia, pseudoanodontia, optic atrophy |
| Complications | N/A |
| Onset | Infancy |
| Duration | Lifelong |
| Types | N/A |
| Causes | Mutations in the ANAPC1 gene |
| Risks | Family history of the condition |
| Diagnosis | Genetic testing, clinical evaluation |
| Differential diagnosis | Other syndromes with similar features |
| Prevention | N/A |
| Treatment | Symptomatic management |
| Medication | N/A |
| Prognosis | Variable, depending on severity |
| Frequency | Rare |
| Deaths | N/A |

GAPO syndrome is a rare genetic disorder characterized by a combination of growth retardation, alopecia, pseudoanodontia, and optic atrophy. The name GAPO is an acronym derived from these primary features. The syndrome is inherited in an autosomal recessive manner.
Signs and Symptoms[edit]
Individuals with GAPO syndrome typically present with the following features:
- Growth retardation: Affected individuals exhibit significantly reduced growth rates, leading to short stature.
- Alopecia: There is a notable absence of hair, including scalp hair, eyebrows, and eyelashes.
- Pseudoanodontia: This refers to the delayed eruption or absence of teeth.
- Optic atrophy: Progressive degeneration of the optic nerve leading to vision impairment.
Additional features may include hearing loss, skin abnormalities, and cardiovascular anomalies.
Genetics[edit]
GAPO syndrome is caused by mutations in the ANKRD11 gene, which plays a role in chromatin remodeling and gene expression. The disorder follows an autosomal recessive inheritance pattern, meaning that an individual must inherit two copies of the mutated gene, one from each parent, to be affected.
Diagnosis[edit]
Diagnosis of GAPO syndrome is primarily based on clinical evaluation and the presence of characteristic features. Genetic testing can confirm the diagnosis by identifying mutations in the ANKRD11 gene.
Management[edit]
There is no cure for GAPO syndrome, and treatment is symptomatic and supportive. Management may involve:
- Regular monitoring of growth and development
- Vision and hearing assessments
- Dental care to address pseudoanodontia
- Supportive therapies for any additional complications
Epidemiology[edit]
GAPO syndrome is extremely rare, with fewer than 50 cases reported in the medical literature. It affects both males and females equally.
See Also[edit]
References[edit]
External Links[edit]
-
